Skip to content
AdminOct 15, 2021< 1 min read

FDA adcomm votes unanimously in support of a J&J Covid-19 booster two months after one-dose shot

The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to authorize a second shot of J&J's COVID-19 vaccine to be administered at least two months after the initial dose. This decision paves the way for individuals to receive an additional dose of the J&J vaccine for enhanced protection against Covid-19.

Read More